bd 1047 has been researched along with morphine in 5 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | bd 1047 (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwasinger, ET; Terashvili, M; Tseng, LF; Wu, HE | 1 |
| Harder, DR; Moore, RM; Terashvili, M; Tseng, LF; Wu, HE | 1 |
| Hong, JS; Tseng, LF; Wu, HE | 1 |
| Chen, SL; Hsu, KY; Huang, EY; Lu, RB; Tao, PL | 1 |
| Hogan, QH; Tseng, LF; Wu, HE | 1 |
5 other study(ies) available for bd 1047 and morphine
| Article | Year |
|---|---|
dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Ethylenediamines; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Rats; Receptors, sigma; Reward; Sigma-1 Receptor; Stereoisomerism | 2007 |
(+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Ethylenediamines; Male; Microinjections; Models, Anatomic; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Periaqueductal Gray; Rats; Receptors, sigma; Stereoisomerism; Tail; Time Factors | 2007 |
Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Ethylenediamines; Injections, Subcutaneous; Male; Mice; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Pentazocine; Receptors, sigma; Stereoisomerism | 2007 |
Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats.
Topics: Analgesics, Opioid; Animals; Antitussive Agents; Behavior, Animal; Conditioning, Psychological; Dextromethorphan; Dose-Response Relationship, Drug; Ethylenediamines; Male; Morphine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, sigma; Reward; Sigma-1 Receptor; Ventral Tegmental Area | 2011 |
(+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord.
Topics: Analgesics, Opioid; Animals; Ethylenediamines; Male; Mice; Morphine; Narcotic Antagonists; Nociception; Pain Measurement; Pentazocine; Reaction Time; Receptors, sigma; Sigma-1 Receptor; Spinal Cord; Tail | 2011 |